Crystalvue Medical Co (ROCO:6527) Cyclically Adjusted FCF per Share: NT$-0.51 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6527 Crystalvue Medical Co Ltd ROCO:6527
93 GF Score
Price NT$67.50
GF Value NT$90.73
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Crystalvue Medical Co Cyclically Adjusted FCF per Share?

Crystalvue Medical Co ROCO:6527 +1.50% 93 Cyclically Adjusted FCF per Share is NT$-0.51 as of Mar. 2026. GuruFocus rates ROCO:6527 with a GF Score™ of 93/100 and a GF Value™ of NT$90.73 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Crystalvue Medical Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was NT$-0.579. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$-0.51 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-01), Crystalvue Medical Co's current stock price is NT$67.50. Crystalvue Medical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was NT$-0.51. Crystalvue Medical Co's Cyclically Adjusted Price-to-FCF of today is .


Crystalvue Medical Co  (ROCO:6527) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Crystalvue Medical Co Cyclically Adjusted FCF per Share Related Terms


Crystalvue Medical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Crystalvue Medical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crystalvue Medical Co Cyclically Adjusted FCF per Share Chart

Crystalvue Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.44

Crystalvue Medical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.44 -0.51

ROCO:6527 vs ISRG, BDX, MDLN: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Crystalvue Medical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Crystalvue Medical Co Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Crystalvue Medical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Crystalvue Medical Co's Cyclically Adjusted Price-to-FCF falls into.


ROCO:6527
93GF Score
Crystalvue Medical Co Ltd ROCO:6527
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crystalvue Medical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Crystalvue Medical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.579/330.2130*330.2130
=-0.579

Current CPI (Mar. 2026) = 330.2130.

Crystalvue Medical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 0.000 233.049 0.000
201412 0.000 234.812 0.000
201506 0.000 238.638 0.000
201512 0.000 236.525 0.000
201606 0.000 241.018 0.000
201612 0.000 241.432 0.000
201706 0.000 244.955 0.000
201712 0.000 246.524 0.000
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 -0.060 254.202 -0.078
201906 0.449 256.143 0.579
201909 -0.312 256.759 -0.401
201912 3.880 256.974 4.986
202003 0.263 258.115 0.336
202006 -0.954 257.797 -1.222
202009 -2.625 260.280 -3.330
202012 2.520 260.474 3.195
202103 -1.923 264.877 -2.397
202106 -13.795 271.696 -16.766
202109 1.582 274.310 1.904
202112 2.603 278.802 3.083
202203 -0.978 287.504 -1.123
202206 0.611 296.311 0.681
202209 1.602 296.808 1.782
202212 0.412 296.797 0.458
202303 -0.403 301.836 -0.441
202306 1.388 305.109 1.502
202309 2.255 307.789 2.419
202312 2.500 306.746 2.691
202403 0.319 312.332 0.337
202406 -1.511 314.175 -1.588
202409 3.175 315.301 3.325
202412 -1.122 315.605 -1.174
202503 0.215 319.799 0.222
202506 -3.132 322.561 -3.206
202509 0.050 324.800 0.051
202512 1.022 324.054 1.041
202603 -0.579 330.213 -0.579

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$-0.51 mean?
Crystalvue Medical Co (ROCO:6527) has a Cyclically Adjusted FCF per Share of NT$-0.51 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Crystalvue Medical Co and its competitors.
Is Crystalvue Medical Co's Cyclically Adjusted FCF per Share too high?
Crystalvue Medical Co's current Cyclically Adjusted FCF per Share is NT$-0.51. Overall, Crystalvue Medical Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crystalvue Medical Co's Cyclically Adjusted FCF per Share compare to ISRG and BDX?
Crystalvue Medical Co's Cyclically Adjusted FCF per Share of NT$-0.51 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Crystalvue Medical Co and its competitors. Crystalvue Medical Co's current Cyclically Adjusted FCF per Share is NT$-0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crystalvue Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Crystalvue Medical Co (ROCO:6527) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$90.73, compared to a current price of NT$67.50 — trading 25.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$-0.51. Crystalvue Medical Co's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Crystalvue Medical Co (ROCO:6527), the current Cyclically Adjusted FCF per Share is NT$-0.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crystalvue Medical Co (ROCO:6527) Overvalued in 2026?

Based on GuruFocus' analysis, Crystalvue Medical Co stock appears to be undervalued. The current stock price of NT$67.50 is trading 25.6% below its estimated GF Value™ of NT$90.73. GuruFocus considers Crystalvue Medical Co to be Modestly Undervalued.

Key valuation signals for ROCO:6527:

  • Cyclically Adjusted FCF per Share: NT$-0.51
  • GF Value™: NT$90.73 vs. price of NT$67.50 (25.6% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6527 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Crystalvue Medical Co Business Description

Address No. 116, Lane 956, Zhongshan Road, Taoyuan District, Taoyuan, TWN, 33072
Crystalvue Medical Co Ltd is engaged in the manufacture and sale of medical devices. Its products include fundus cameras, optical coherence tomography (OCT) systems, tonometers, digital microscope cameras, lens edgers, and gastrointestinal endoscopic disposable devices, among others.
93GF Score

Get the complete analysis for ROCO:6527

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$67.50
Price
NT$90.73
GF Value